Additional File 2 of Label-free Proteomic Analysis of Serum Exosomes from Paroxysmal Atrial Fibrillation Patients

Hanwen Ni,Wei Pan,Jin Qi,Yunpeng Xie,Zengping Ning,Kang Chen,Tianyou Lin,Changjian Lin,Ying Xie,Jiemin Wu,Peng Ni,Liqun Wu

DOI: https://doi.org/10.6084/m9.figshare.13532089

2021-01-01

Abstract:Additional file 2: Table S2. List of protein quantification and differential analysis.

What problem does this paper attempt to address?

Label-free Proteomic Analysis of Serum Exosomes from Paroxysmal Atrial Fibrillation Patients

Ni Hanwen,Pan Wenqi,Jin Qi,Xie Yucai,Zhang Ning,Chen Kang,Lin Tianyou,Lin Changjian,Xie Yun,Wu Jiemin,Ni Peihua,Wu Liqun

DOI: https://doi.org/10.1186/s12014-020-09304-8

2021-01-01

Clinical Proteomics

Abstract:Background Atrial fibrillation (AF) is the most common cardiac heterogeneous rhythm disorder. It represents a major cause of mortality and morbidity, mainly related to embolic events and heart failure. Mechanisms of AF are complex and remain incompletely understood. Recent evidence suggests exosomes are membrane-coated objects released by many cell-types. Their presence in body fluids and the variable surface composition and content render them attractive as a mechanism for potential biomarkers. However, the content of serum exosomes of AF patients has not been fully delineated. Methods In this work, the serum exosomes from AF patients and healthy donors were used to compare changes in the exosome protein content. Exosomes were isolated from serum of AF patients and healthy donors and their purity was confirmed by Western blotting assays and transmission electron microscopy (TEM). Label-free LC–MS/MS quantitative proteomic analysis was applied to analyze protein content of serum exosomes. Results A total of 440 exosomal protein groups were identified, differentially expressed proteins were filtrated with fold change ≥ 2.0 (AF/controls protein abundance ratio ≥ 2 or ≤ 0.5) and p value less than 0.05 (p < 0.05), significantly changed in abundance group contains 39 elevated proteins and 18 reduced proteins, while consistent presence/absence expression profile group contains 40 elevated proteins and 75 reduced proteins. Bioinformatic analysis of differential exosomal proteins confirmed the significant enrichment of components involved in the anticoagulation, complement system and protein folding. Parallel-Reaction Monitoring Relative Quantitative Analysis (PRM) further suggested that AF related to complement system and protein folding. Conclusions These results revealed the composition and potential function of AF serum exosomes, thus providing a new perspective on the complement system and protein folding to AF.
Additional File 2 of Identification of Genes and Key Pathways Underlying the Pathophysiological Association Between Nonalcoholic Fatty Liver Disease and Atrial Fibrillation

Yanan Chu,Fangcong Yu,Yakui Wu,Jing Yang,Jiaran Shi,Tianxin Ye,Deheng Han,Xingxiang Wang

DOI: https://doi.org/10.6084/m9.figshare.20236361

2022-01-01

Abstract:Additional file 2. DEGs involved in AF samples.
Supplementary Figure 1 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren Averett Byers,Jing Wang,Monique B. Nilsson,Junya Fujimoto,Pierre Saintigny,John Yordy,Uma Giri,Michael Peyton,You Hong Fan,Lixia Diao,Fatemeh Masrorpour,Li Shen,Wenbin Liu,Boris Duchemann,Praveen Tumula,Vikas Bhardwaj,James Welsh,Stephanie Weber,Bonnie S. Glisson,Neda Kalhor,Ignacio I. Wistuba,Luc Girard,Scott M. Lippman,Gordon B. Mills,Kevin R. Coombes,John N. Weinstein,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/2159-8290.22528440.v1

2023-01-01

Abstract:PDF file, 125K, Western blot of total PARP1.
Supplementary Table 7 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren A. Byers,Jing Wang,Monique B. Nilsson,Junya Fujimoto,Pierre Saintigny,John S. Yordy,Uma Giri,Michael Peyton,You Hong Fan,Lixia Diao,Fatemeh Masrorpour,Li Shen,Wenbin Liu,Boris Duchemann,Praveen K. Tumula,Vikas Bhardwaj,James Welsh,Stephanie Weber,Bonnie S. Glisson,Neda Kalhor,Ignacio I. Wistuba,Luc Girard,Scott M. Lippman,Gordon B. Mills,Kevin R. Coombes,John N. Weinstein,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/2159-8290.22528410.v1

2023-01-01

Abstract:PDF file, 95K, Antibodies used in reverse-phase protein microarrays
Differential Proteome Profiling of Pleural Effusions from Lung Cancer and Benign Inflammatory Disease Patients

Zhengyang Wang,Cheng Wang,Xiaobin Huang,Ying Shen,Jing Shen,Kejing Ying

DOI: https://doi.org/10.1016/j.bbapap.2012.01.016

2012-01-01

Biochimica et Biophysica Acta

Abstract:The pleural effusion proteome has been found containing information that directly reflects pathophysiological status and represents a potential diagnostic value for pulmonary diseases. However, the variability in protein composition between malignant and benign effusions is not well understood. Herein, we investigated the changes of proteins in pleural effusions from lung adenocarcinoma and benign inflammatory disease (pneumonia and tuberculosis) patients by two-dimensional difference gel electrophoresis (2D-DIGE). Twenty-eight protein spots displayed significantly different expression levels were positively identified by MALDI-TOF-MS representing 16 unique proteins. Five identified protein candidates were further validated and analyzed in effusions, sera or tissues. Among them, hemopexin, fibrinogen gamma and transthyretin (TTR) were up-regulated in cancer samples. The effusion concentration of serum amyloid P component (SAP) was significantly lower in lung cancer patients than in benign inflammatory patients, but no differences were found in sera samples. Moreover, a Jumonji C (JmjC)-domain-containing protein, JMJD5, was observed to be down-regulated in malignant effusions, lung cancer tissues and cancer cells. These results shed light on the altered pleural effusion proteins as a useful and important complement to plasma or other routine clinical tests for pulmonary disease diagnosis.
Supplementary Table 2 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren Averett Byers,Jing Wang,Monique B. Nilsson,Junya Fujimoto,Pierre Saintigny,John Yordy,Uma Giri,Michael Peyton,You Hong Fan,Lixia Diao,Fatemeh Masrorpour,Li Shen,Wenbin Liu,Boris Duchemann,Praveen Tumula,Vikas Bhardwaj,James Welsh,Stephanie Weber,Bonnie S. Glisson,Neda Kalhor,Ignacio I. Wistuba,Luc Girard,Scott M. Lippman,Gordon B. Mills,Kevin R. Coombes,John N. Weinstein,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/2159-8290.22528425

2023-01-01

Abstract:PDF file, 64K, Non-small cell lung cancer cell lines.
Proteomic profiles of patients with atrial fibrillation provide candidate biomarkers for diagnosis

WeiYi Zhong,Hui Yang,YuLin Wang,Ye Yang,ChangFa Guo,ChunSheng Wang,Qiang Ji

DOI: https://doi.org/10.1016/j.ijcard.2021.09.047

IF: 4.039

2021-12-01

International Journal of Cardiology

Abstract:BackgroundAtrial fibrillation (AF) is the most common cardiac arrhythmia worldwide with an increasing risk of heart failure, stroke, and thromboembolic events. Currently distinct pathophysiological mechanisms during AF development and valuable biomarkers for AF management remain unknown.MethodsIn this study, we collected peripheral plasma samples from 18 non-valvular AF patients and 10 controls. A LC-MS/MS-DIA-based quantitative proteomic analysis, as well as bioinformatic analysis, was performed for discovery of differentially expressed proteins (DEPs) and dysregulated pathways. Next, we utilized enzyme-linked immunosorbent assay (ELISA) to validate selected DEPs and assessed their abilities for discrimination in another group of 20 AF patients and 10 controls.ResultsThe plasma proteome provided evidence for vital roles of abnormal inflammation, hemostasis, tissue remodeling and metabolism in AF patients. Differences between paroxysmal and persistent AF mainly lie in proteins or pathways related to hemostasis and cardiac remodeling. In addition, we successfully validated up-regulated proteins of platelet factor 4 variant 1 (PF4V1), thrombospondin-1 (THBS1), platelet basic protein (PBP) and fructose-bisphosphate aldolase A (ALDOA) in another group, which could make discrimination between AF patients and controls.ConclusionsOur pilot proteomic study provided candidate biomarkers of PF4V1, THBS1, PBP and ALODA with the hope of application in AF management. And we showed the differences in pathophysiological mechanisms between paroxysmal and persistent AF. They mainly focused on pathways of hemostasis and cardiac remodeling, which could be a valuable clue for further research on AF progression.

cardiac & cardiovascular systems
Proteomic Analysis Of Atrial Appendages Revealed The Pathophysiological Changes Of Atrial Fibrillation

Ban Liu,Xiang Li,Cuimei Zhao,Yuliang Wang,Mengwei Lv,Xin Shi,Chunyan Han,Pratik Pandey,Chunhua Qian,Changfa Guo,Yangyang Zhang

DOI: https://doi.org/10.3389/fphys.2020.573433

IF: 4

2020-01-01

Frontiers in Physiology

Abstract:Atrial fibrillation (AF), known as the most common arrhythmia in the developed world, affects 1.5-2.0% of the population. Numerous basic studies have been carried out to identify the roles of electric and structural remodeling in the pathophysiological changes of AF, but more explorations are required to further understand the mechanisms of AF development. Proteomics enables researchers to identify protein alterations responsible for the pathological developing progresses of diseases. Compared to the genome, the proteome is closely related to the disease phenotype and can better manifest the progression of diseases. In this study, AF patients proteomically analyzed to identify possible mechanisms. Totally 20 patients undergoing cardiac surgery (10 with paroxysmal AF and 10 with persistent AF) and 10 healthy subjects were recruited. The differentially expressed proteins identified here included AKR1A1, LYZ, H2AFY, DDAH1, FGA, FGB, LAMB1, LAMC1, MYL2, MYBPC3, MYL5, MYH10, HNRNPU, DKK3, COPS7A, YWHAQ, and PAICS. These proteins were mainly involved in the development of structural remodeling. The differently expressed proteins may provide a new perspective for the pathological process of AF, and may enable useful targets for drug interference. Nevertheless, more research in terms of multi-omics is required to investigate possible implicated molecular pathways of AF development.
Protomic Profiles of Patients with Atrial Fibrillation Provide New Candidate Biomakers for Diagnosis

WeiYi Zhong,Hui Yang,YuLin Wang,Ye Yang,Chang Fa Guo,Chun Sheng Wang,Qiang Ji

DOI: https://doi.org/10.2139/ssrn.3520027

2020-01-01

SSRN Electronic Journal

Abstract:Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide with an increasing risk of heart failure, stroke and thromboembolic events. Currently the final diagnosis of AF is usually made via electrocardiogram (ECG), pulse palpation and modified blood pressure monitors. However, all above methods mostly greatly rely on the onset of AF, impeding the early diagnosis and timely treatment of paroxysmal AF patients. We aimed to find differentially expressed protein between peripheral plasma of AF and non-AF patients and provide candidate biomarkers for diagnosis or prognosis.Methods: In this study, we collected peripheral plasma samples from patients with and without AF and performed a LC-MS/MS-DIA-based quantitative proteomic analysis for biomarkers discovery. Next, we utilized western blotting to validate selected differentially expressed proteins and assessed their diagnostic efficiency.Findings:We successfully discovered and validated up-regulated proteins of platelet factor 4 variant (PF4V1), thrombospondin-1 (THBS-1) and platelet basic protein(PBP) in AF patients with fold change over 4 related to hypercoagulation and prothrombotic state. The assessment of their diagnostic efficiency demonstrated area under the receptor-operating characteristic curve values over 0.8.Interpretation: We identified significantly differentially expressed proteins between AF and non-AF patients closely connected to hypercoagulation and prothrombotic state, which provide new candidate biomarkers for diagnosis and prognosis of AF.Funding Statement: This work was supported by the National Natural Science Foundation of China (NSFC No. 81770341) (Q.J.).Declaration of Interests: All authors declare no competing interests.Ethics Approval Statement: This study protocol was approved by the ethics committee of Zhongshan Hospital Fudan University, and all participants gave their informed consent.
Additional File 2 of Label-free Proteomics Uncovers SMC1A Expression is Down-regulated in AUB-E

Yingxian Jia,Jingqin Luo,Yibing Lan,Chunming Li,Linjuan Ma,Xiaoming Zhu,Fei Ruan,Jianhong Zhou

DOI: https://doi.org/10.6084/m9.figshare.14151242

2021-01-01

Abstract:Additional file 2: Supplementary Table S2. different proteins in human endometrium between AUB-E and control.
Quantitative Proteomic Analysis to Identify Differentially Expressed Proteins in the Persistent Atrial Fibrillation Using TMT Coupled with Nano-Lc-ms/ms

Hailong Cao,Xiyu Zhu,Xin Chen,Yining Yang,Qing Zhou,Wei Xu,Dongjin Wang

2020-01-01

American journal of translational research

Abstract:Persistent atrial fibrillation (PeAF) is a progressive cardiovascular disease with a high risk for most patients after diagnosis. Poor molecular description of PeAF has led to unsatisfactory interpretation of the pathogenesis of it, resulting in the lack of effective treatments. The aim of the present study was to find several new potential biomarkers for early prevention, diagnosis and treatment of this disease and explore the underlying molecular mechanisms. An absolute quantitation Tandem Mass Tag (TMT)-liquid chromatography-tandem mass spectrometry (LC-MS/MS) approach was applied to identify differentially expressed proteins (DEPs) in left atrial appendage. Totally, 4682 proteins were identified and 4159 proteins were quantified. Compared with control subjects, 118 DEPs (85 upregulated proteins and 33 downregulated proteins) were identified in the atrial tissues of PeAF patients. Using String software, a regulatory network containing 87 nodes and 244 edges was built, and the functional enrichment showed that DEPs were predominantly involved in protein digestion and absorption, regulation of metabolism and focal adhesion. Four proteins, collagen 1 (COL-I), collagen 2 (COL-II), ras-related protein 1 (RAP1) and leucine-rich alpha-2-glycoprotein 1 (LRG1) were selected for validation using Western blot analysis to distinguish PeAF patients and control subjects. The present results provide a comprehensive understanding of the pathophysiological mechanisms of PeAF and the validated biomarkers for the diagnosis of PeAF, which facilitate the development of therapeutic targets.
Proteomic Analysis of the Serum in Patients with Idiopathic Pulmonary Arterial Hypertension

Yu Min,Wang Xing-xiang,Zhang Fu-rong,Shang Yun-peng,Du Yu-xi,Chen Hong-juan,Chen Jun-zhu

DOI: https://doi.org/10.1631/jzus.2007.b0221

2007-01-01

Journal of Zhejiang University SCIENCE B

Abstract:Idiopathic pulmonary arterial hypertension (IPAH) is a rare disease of unknown etiology. The exact pathogenesis of pulmonary arterial hypertension is still not well known. In the past decades, many protein molecules have been found to be involved in the development of IPAH. With proteomic techniques, profiling of human plasma proteome becomes more feasible in searching for disease-related markers. In present study, we showed the protein expression profiles of the serum of IPAH and healthy controls after depleting a few high-abundant proteins in serum. Thirteen spots had changed significantly in IPAH compared with healthy controls and were identified by LC-MS/MS. Alpha-1-antitrypsin and vitronectin were down-regulated in IPAH and may be valuable candidates for further explorations of their roles in the development of IPAH.
Additional File 4 of Quartet Protein Reference Materials and Datasets for Multi-Platform Assessment of Label-Free Proteomics

Sha Tian,Dongdong Zhan,Ying Yu,Yunzhi Wang,Mingwei Liu,Sheng-Li Tan,Yan Li,Lei Song,Zhaoyu Qin,Xianju Li,Lu Yang,Yao Li,Shuhui Ji,Shanshan Wang,Yuanting Zheng,Fuchu He,Jun Qin,Ding Chen

DOI: https://doi.org/10.6084/m9.figshare.24098160

2023-01-01

Abstract:Additional file 4: Table S3. Downregulated proteins.
Proteomic analysis to identify differentially expressed proteins between subjects with metabolic healthy obesity and non-alcoholic fatty liver disease.

Xianwen Yuan,Yuanyuan Sun,Qi Cheng,Kai Hu,Juan Ye,Yinjuan Zhao,Jing Wu,Xiaoyan Shao,Lei Fang,Yitao Ding,Xitai Sun,Xiaolei Shi,Bin Xue

DOI: https://doi.org/10.1016/j.jprot.2020.103683

IF: 3.855

2020-01-01

Journal of Proteomics

Abstract:Obese subjects with non-alcoholic fatty liver disease (NAFLD) and considered metabolically healthy have not been well differentiated. In this study, obese subjects were divided into metabolic healthy obesity (MHO) and NAFLD groups. Liver tissues were sampled from these two types of subjects undergoing bariatric surgery, and proteins in the liver tissues that expressed differently between the two groups of subjects were identified by Tandem Mass Tags (TMT) assay. Compared with the MHO group, 132 proteins were found to be upregulated and 84 proteins were found to be downregulated (mainly localized in mitochondria) in NAFLD group. The KEGG pathway analysis showed that significantly upregulated metabolic pathways include PPAR signaling, ECM-receptor interaction and oxidative phosphorylation was significantly downregulated. The GO analysis revealed that upregulated proteins were involved in extracellular structure organization, extracellular matrix organization and downregulated proteins took part in the oxidation–reduction process and so on. FBLN5 and DHRS2 were further validated by Western blot, immunohistochemistry and ELISA. All results demonstrate that FBLN5 expression was significantly upregulated but DHRS2 was significantly downregulated.
Label-free quantitative proteomic analysis of serum exosomes in mice with thoracic aortic aneurysm

Jia Xu,Jiacheng Liu,Yibai Qu,Linhui Jiang,Rongxin Liang,Bohai Li,Lei Li,Yong Jiang,Lei Li and Yong Jiang

DOI: https://doi.org/10.1186/s12953-023-00220-x

2023-10-25

Proteome Science

Abstract:Thoracic aortic aneurysm (TAA) is a cardiovascular disease with high morbidity and mortality. However, the causes and mechanisms of TAA are not fully understood. Serum exosomes from mice with TAA were used to explore the markers associated with this disease.

biochemical research methods
Additional File 3 of Integrative Proteomic Characterization of Trace FFPE Samples in Early-Stage Gastrointestinal Cancer

Lingling Li,Hui Liu,Yan Li,Chunmei Guo,Bing Wang,Dan Shen,Qiao Zhang,Ding Chen

DOI: https://doi.org/10.6084/m9.figshare.19572594

2022-01-01

Abstract:Additional file 3: Supplementary Table S2. Matrix of identified phophoproteins in EESCC and EDAC.
Proteomic Characterization of Transfusable Blood Components: Fresh Frozen Plasma, Cryoprecipitate, and Derived Extracellular Vesicles via Data-Independent Mass Spectrometry

Ji Hui Hwang,Andrew Lai,John-Paul Tung,Damien G Harkin,Robert L Flower,Natalie M Pecheniuk

DOI: https://doi.org/10.1021/acs.jproteome.4c00417

2024-10-04

Abstract:Extracellular vesicles (EVs) are a heterogeneous collection of particles that play a crucial role in cell-to-cell communication, primarily due to their ability to transport molecules, such as proteins. Thus, profiling EV-associated proteins offers insight into their biological effects. EVs can be isolated from various biological fluids, including donor blood components such as cryoprecipitate and fresh frozen plasma (FFP). In this study, we conducted a proteomic analysis of five single donor units of cryoprecipitate, FFP, and EVs derived from these blood components using a quantitative mass spectrometry approach. EVs were successfully isolated from both cryoprecipitate and FFP based on community guidelines. We identified and quantified approximately 360 proteins across all sample groups. Principal component analysis and heatmaps revealed that both cryoprecipitate and FFP are similar. Similarly, EVs derived from cryoprecipitate and FFP are comparable. However, they differ between the originating fluids and their derived EVs. Using the R-package MS-DAP, differentially expressed proteins (DEPs) were identified. The DEPs for all comparisons, when submitted for gene enrichment analysis, are involved in the complement and coagulation pathways. The protein profile generated from this study will have important clinical implications in increasing our knowledge of the proteins that are associated with EVs derived from blood components.
Identifying plasma proteomic signatures from health to heart failure, across the ejection fraction spectrum

Karolina Andrzejczyk,Sabrina Abou Kamar,Anne-Mar van Ommen,Elisa Dal Canto,Teun B Petersen,Gideon Valstar,K Martijn Akkerhuis,Maarten Jan Cramer,Victor Umans,Frans H Rutten,Arco Teske,Eric Boersma,Roxana Menken,Bas M van Dalen,Leonard Hofstra,Marianne Verhaar,Jasper Brugts,Folkert Asselbergs,Hester den Ruijter,Isabella Kardys

DOI: https://doi.org/10.1038/s41598-024-65667-0

2024-06-27

Abstract:Circulating proteins may provide insights into the varying biological mechanisms involved in heart failure (HF) with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF). We aimed to identify specific proteomic patterns for HF, by comparing proteomic profiles across the ejection fraction spectrum. We investigated 4210 circulating proteins in 739 patients with normal (Stage A/Healthy) or elevated (Stage B) filling pressures, HFpEF, or ischemic HFrEF (iHFrEF). We found 2122 differentially expressed proteins between iHFrEF-Stage A/Healthy, 1462 between iHFrEF-HFpEF and 52 between HFpEF-Stage A/Healthy. Of these 52 proteins, 50 were also found in iHFrEF vs. Stage A/Healthy, leaving SLITRK6 and NELL2 expressed in lower levels only in HFpEF. Moreover, 108 proteins, linked to regulation of cell fate commitment, differed only between iHFrEF-HFpEF. Proteomics across the HF spectrum reveals overlap in differentially expressed proteins compared to stage A/Healthy. Multiple proteins are unique for distinguishing iHFrEF from HFpEF, supporting the capacity of proteomics to discern between these conditions.
Analysis of Differentially Expressed Proteome in Urinary Exosome from Non-small Cell Lung Cancer Patients

Yan Li

2010-01-01

CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (CHINESE VERSION)

Abstract:Urine provides an alternative to blood plasma as a potential source of disease biomarkers. Exosomes was separated by ultracentrifuge at 200000 g in normal persons and non-small cell lung cancer ( NSCLC) patients′ urine. For proteomic analysis of urinary exosome,1D sodium dodecylsulfonate-polyacrylate gel electrophoresis( SDS-PAGE) was carries out and cut the gel 31 kDa-20 kDa bands in normal group and disease group′s. These gel blocks were subjected to in-gel trypsinization,and the extracted peptides were analyzed HPLC-CHIP-MS/MS. Approximately 24 unique proteins were identified in the UniProtKB/SWISSPORT. The difference expression proteins were found in urinary exosome from NSCLC patients,including three fragment of the immunoglobulin kappa,two kinds of Ras related proteins,glutathione S-transferase A2, serum amyloid P-component precursor and phosphatidylethanolamine-binding protein 1.
Additional File 1 of Proteomic Differences Between Extracellular Vesicles and Extracellular Vesicle-Depleted Excretory/secretory Products of Barber’s Pole Worm

Fei Wu,Xueqiu Chen,Zhendong Du,Yanqiong Chen,Danni Tong,Jingju Zhang,Yi Yang,Guorong Ma,Aifang Du

DOI: https://doi.org/10.6084/m9.figshare.24993733

2024-01-01

Abstract:Additional file 1: Table S1. Proteins identified in the small extracellular vesicles (EVs) and EV-depleted excretory/secretory products (ESPs) of Haemonchus contortus.

Additional File 2 of Label-free Proteomic Analysis of Serum Exosomes from Paroxysmal Atrial Fibrillation Patients

Label-free Proteomic Analysis of Serum Exosomes from Paroxysmal Atrial Fibrillation Patients

Additional File 2 of Identification of Genes and Key Pathways Underlying the Pathophysiological Association Between Nonalcoholic Fatty Liver Disease and Atrial Fibrillation

Supplementary Figure 1 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Table 7 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Differential Proteome Profiling of Pleural Effusions from Lung Cancer and Benign Inflammatory Disease Patients

Supplementary Table 2 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Proteomic profiles of patients with atrial fibrillation provide candidate biomarkers for diagnosis

Proteomic Analysis Of Atrial Appendages Revealed The Pathophysiological Changes Of Atrial Fibrillation

Protomic Profiles of Patients with Atrial Fibrillation Provide New Candidate Biomakers for Diagnosis

Additional File 2 of Label-free Proteomics Uncovers SMC1A Expression is Down-regulated in AUB-E

Quantitative Proteomic Analysis to Identify Differentially Expressed Proteins in the Persistent Atrial Fibrillation Using TMT Coupled with Nano-Lc-ms/ms

Proteomic Analysis of the Serum in Patients with Idiopathic Pulmonary Arterial Hypertension

Additional File 4 of Quartet Protein Reference Materials and Datasets for Multi-Platform Assessment of Label-Free Proteomics

Proteomic analysis to identify differentially expressed proteins between subjects with metabolic healthy obesity and non-alcoholic fatty liver disease.

Label-free quantitative proteomic analysis of serum exosomes in mice with thoracic aortic aneurysm

Additional File 3 of Integrative Proteomic Characterization of Trace FFPE Samples in Early-Stage Gastrointestinal Cancer

Proteomic Characterization of Transfusable Blood Components: Fresh Frozen Plasma, Cryoprecipitate, and Derived Extracellular Vesicles via Data-Independent Mass Spectrometry

Identifying plasma proteomic signatures from health to heart failure, across the ejection fraction spectrum

Analysis of Differentially Expressed Proteome in Urinary Exosome from Non-small Cell Lung Cancer Patients

Additional File 1 of Proteomic Differences Between Extracellular Vesicles and Extracellular Vesicle-Depleted Excretory/secretory Products of Barber’s Pole Worm